Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients

Abstract Background The COVID‐19 pandemic has disrupted medical care, increased isolation, and exacerbated anxiety in breast cancer patients. Since March 2020, Breastcancer.org experienced a sustained surge in requested pandemic‐related information and support. To characterize the pandemic‐related e...

Full description

Bibliographic Details
Main Authors: Yash B. Shah, Stephanie Kjelstrom, Diana Martinez, Adam Leitenberger, Donna‐Marie Manasseh, Melissa Bollmann‐Jenkins, Ann Partridge, Virginia Kaklamani, Rowen Chlebowski, Sharon Larson, Marisa Weiss
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.5184
_version_ 1797903079619690496
author Yash B. Shah
Stephanie Kjelstrom
Diana Martinez
Adam Leitenberger
Donna‐Marie Manasseh
Melissa Bollmann‐Jenkins
Ann Partridge
Virginia Kaklamani
Rowen Chlebowski
Sharon Larson
Marisa Weiss
author_facet Yash B. Shah
Stephanie Kjelstrom
Diana Martinez
Adam Leitenberger
Donna‐Marie Manasseh
Melissa Bollmann‐Jenkins
Ann Partridge
Virginia Kaklamani
Rowen Chlebowski
Sharon Larson
Marisa Weiss
author_sort Yash B. Shah
collection DOAJ
description Abstract Background The COVID‐19 pandemic has disrupted medical care, increased isolation, and exacerbated anxiety in breast cancer patients. Since March 2020, Breastcancer.org experienced a sustained surge in requested pandemic‐related information and support. To characterize the pandemic‐related experiences of breast cancer patients, we surveyed the Breastcancer.org Community early in the COVID‐19 era. Methods Breastcancer.org Community members were invited to complete an online questionnaire regarding their experience during the pandemic. Self‐reported data on demographics, comorbidities, care disruptions, anxiety, coping ability, telemedicine use, and satisfaction with care were collected. Results were analyzed using Stata 16.0 (Stata Corp., Inc). Results Included were 568 current and previous breast cancer patients, primarily with U.S. residence. Overall, 43.8% reported at least one comorbidity associated with severe COVID‐19 illness and 61.9% experienced care delays. Moderate to extreme anxiety about contracting COVID‐19 was reported by 36.5%, increasing with number of comorbidities (33.0% vs. 55.4%, p = 0.021), current breast cancer diagnosis (30.4% vs. 42.5%, p = 0.011), and poorer coping ability (15.5% vs. 53.9%, p < 0.0001). Moderate to extreme anxiety about cancer care disruptions was reported by 29.1%, increasing with current breast cancer diagnosis (19.1% vs. 38.9%, p < 0.0001), actual delayed care (18.9% vs. 35.3%, p < 0.0001), and poorer coping ability (13.1% vs. 57.7%, p < 0.0001). Most utilized telehealth and found it helpful, but also expressed increased anxiety and subjectively expressed that these were less preferable. Conclusion Early in the COVID‐19 pandemic, anxiety was reported by a large proportion of breast cancer patients, with increased prevalence in those with risk factors. Attention to mental health is critical, as emotional distress not only harms quality of life but may also compromise outcomes.
first_indexed 2024-04-10T09:27:19Z
format Article
id doaj.art-1f8ae1280084487fba9f26b77c5363f1
institution Directory Open Access Journal
issn 2045-7634
language English
last_indexed 2024-04-10T09:27:19Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj.art-1f8ae1280084487fba9f26b77c5363f12023-02-19T18:54:08ZengWileyCancer Medicine2045-76342023-02-011233577358810.1002/cam4.5184Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patientsYash B. Shah0Stephanie Kjelstrom1Diana Martinez2Adam Leitenberger3Donna‐Marie Manasseh4Melissa Bollmann‐Jenkins5Ann Partridge6Virginia Kaklamani7Rowen Chlebowski8Sharon Larson9Marisa Weiss10Sidney Kimmel Medical College Thomas Jefferson University Philadelphia Pennsylvania USAMain Line Health Center for Population Health Research Lankenau Institute for Medical Research Wynnewood Pennsylvania USADepartment of Psychiatry Columbia University Irving Medical Center New York New York USABreastcancer.org Ardmore Pennsylvania USADepartment of Surgery Maimonides Medical Center Brooklyn New York USABreastcancer.org Ardmore Pennsylvania USADepartment of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USADivision of Hematology/Oncology UT Health San Antonio San Antonio Texas USAThe Lundquist Institute, Harbor‐UCLA Medical Center Torrance California USAMain Line Health Center for Population Health Research Lankenau Institute for Medical Research Wynnewood Pennsylvania USABreastcancer.org Ardmore Pennsylvania USAAbstract Background The COVID‐19 pandemic has disrupted medical care, increased isolation, and exacerbated anxiety in breast cancer patients. Since March 2020, Breastcancer.org experienced a sustained surge in requested pandemic‐related information and support. To characterize the pandemic‐related experiences of breast cancer patients, we surveyed the Breastcancer.org Community early in the COVID‐19 era. Methods Breastcancer.org Community members were invited to complete an online questionnaire regarding their experience during the pandemic. Self‐reported data on demographics, comorbidities, care disruptions, anxiety, coping ability, telemedicine use, and satisfaction with care were collected. Results were analyzed using Stata 16.0 (Stata Corp., Inc). Results Included were 568 current and previous breast cancer patients, primarily with U.S. residence. Overall, 43.8% reported at least one comorbidity associated with severe COVID‐19 illness and 61.9% experienced care delays. Moderate to extreme anxiety about contracting COVID‐19 was reported by 36.5%, increasing with number of comorbidities (33.0% vs. 55.4%, p = 0.021), current breast cancer diagnosis (30.4% vs. 42.5%, p = 0.011), and poorer coping ability (15.5% vs. 53.9%, p < 0.0001). Moderate to extreme anxiety about cancer care disruptions was reported by 29.1%, increasing with current breast cancer diagnosis (19.1% vs. 38.9%, p < 0.0001), actual delayed care (18.9% vs. 35.3%, p < 0.0001), and poorer coping ability (13.1% vs. 57.7%, p < 0.0001). Most utilized telehealth and found it helpful, but also expressed increased anxiety and subjectively expressed that these were less preferable. Conclusion Early in the COVID‐19 pandemic, anxiety was reported by a large proportion of breast cancer patients, with increased prevalence in those with risk factors. Attention to mental health is critical, as emotional distress not only harms quality of life but may also compromise outcomes.https://doi.org/10.1002/cam4.5184anxietybreast cancerCOVID‐19mental healthpatient‐reported experiencesscreening
spellingShingle Yash B. Shah
Stephanie Kjelstrom
Diana Martinez
Adam Leitenberger
Donna‐Marie Manasseh
Melissa Bollmann‐Jenkins
Ann Partridge
Virginia Kaklamani
Rowen Chlebowski
Sharon Larson
Marisa Weiss
Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
Cancer Medicine
anxiety
breast cancer
COVID‐19
mental health
patient‐reported experiences
screening
title Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
title_full Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
title_fullStr Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
title_full_unstemmed Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
title_short Risk factors for heightened COVID‐19‐Related anxiety among breast cancer patients
title_sort risk factors for heightened covid 19 related anxiety among breast cancer patients
topic anxiety
breast cancer
COVID‐19
mental health
patient‐reported experiences
screening
url https://doi.org/10.1002/cam4.5184
work_keys_str_mv AT yashbshah riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT stephaniekjelstrom riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT dianamartinez riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT adamleitenberger riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT donnamariemanasseh riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT melissabollmannjenkins riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT annpartridge riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT virginiakaklamani riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT rowenchlebowski riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT sharonlarson riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients
AT marisaweiss riskfactorsforheightenedcovid19relatedanxietyamongbreastcancerpatients